吉林敖东 (000623)
Jilin Aodong Pharmaceutical Group Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 119589.54
- Circulating A-Shares(W): 119102.34
- Earnings Per Share(RMB): 1.9262
- Net Assets Per Share(RMB): 25.5610
- Operating Revenue(W RMB): 164031.45
- Total Profit(W RMB): 234370.02
- Net Profit Attributable to Parent(W RMB): 226049.64
- Net Profit Growth Rate(%): 81.70
- Weighted Return on Equity(%): 7.5600
- Operating Cash Flow Per Share(RMB): 0.1350
- Undistributed Profit Per Share(RMB): 17.9437
- Capital Reserve Per Share(RMB): 4.0952
2. Main Business
The main business covers:
- Research, manufacturing and sales of traditional Chinese medicine
- Research, manufacturing and sales of chemical drugs
3. Company Basic Information
- Company Name: Jilin Aodong Pharmaceutical Group Co., Ltd.
- Listing Date: 1996-10-28
- Industry: Pharmaceutical Manufacturing
- Address: No. 2158, Aodong Street, Dunhua City, Jilin Province, China
- Website: www.jlaod.com
- Company Profile: The company's predecessor was Yanbian State-owned Dunhua Deer Farm. In February 1992, it was jointly established by Yanbian Aodong Group Company and two other companies. Initially, its net assets and cash investment were converted into 36.658 million state shares, 10 million promoter shares, 23.742 million private placement legal person shares, and 17.6 million employee shares. In August 1994, the total shares were adjusted to 58 million shares; after the first online pricing issuance from October 8 to 16, 1996, the total shares at listing were 71.6 million shares; 4.4 million internal employee shares were listed for trading together with its public shares on October 28, 1996.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Dunhua Jincheng Industrial Co., Ltd. | General Legal Person | 32708.07 | 27.46 |
| 2 | GF Securities Co., Ltd. | Securities Firm | 4322.05 | 3.63 |
| 3 | Jilin Aodong Pharmaceutical Group Co., Ltd. - Phase 1 Employee Stock Ownership Plan | General Legal Person | 2550.27 | 2.14 |
| 4 | CSI 500 Exchange Traded Open-end Index Securities Investment Fund | Fund | 1393.00 | 1.17 |
| 5 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 1181.75 | 0.99 |
| 6 | Guangdong Dehui Investment Management Co., Ltd. - Dehui Global Select Private Securities Investment Fund | Private Securities Investment Fund | 797.51 | 0.67 |
| 7 | Yanbian State-owned Assets Management Corporation | General Legal Person | 607.99 | 0.51 |
| 8 | ChinaAMC CSI Traditional Chinese Medicine Exchange Traded Open-end Index Securities Investment Fund | Fund | 597.74 | 0.50 |
| 9 | Penghua CSI Traditional Chinese Medicine Exchange Traded Open-end Index Securities Investment Fund | Fund | 223.70 | 0.19 |
| 10 | China Merchants CSI 500 Equal Weight Index Enhanced Securities Investment Fund Class A | Fund | 50.20 | 0.04 |
5. Concept Sectors
- Venture Capital Concept
- Infant and Child Concept
- Rural Revitalization
- Industrial Internet
- Internet Celebrity Economy
- Mask Protection
- Helicobacter Pylori
- Hepatitis Concept
- Innovative Drugs
- Margin Trading & Securities Lending
- Financial Shareholding
- Low Price-to-Book Ratio
- Low Price-to-Earnings Ratio
- High-Performance Stocks
- Securities Firm Heavy Holdings
- Below Net Asset Value
- MSCI Mid Cap
- SZSE Value
- SZSE Component Index
- Small Cap Value
- SZSE 300
- CNI Value
- CSI Buyback
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information